Search Results 251-260 of 2220 for 搜索引擎yandex咨询邮箱：lgooxc@hotmail.com

1. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.

2. Follow-on Study of Coagulation Function in Patients with AERD (Aspirin Exacerbated Respiratory Disease) - Mayo Clinic

   The purpose of this study is to better characterize the extent the pathways involved in AERD (leukotriene, prostaglandin, and thromboxane) impact coagulation ...

3. Faculty - Department of Biochemistry and Molecular Biology - Mayo Clinic Research

   To learn more about the research interests of individual faculty members in the Department of Biochemistry and Molecular Biology, including their location, ...

4. A Study to Evaluate the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors - Mayo Clinic

   The purpose of this study is to evaluate the feasibility of twice daily memantine started before radiation therapy (RT) and continued one month after radiation ...

5. Genomic Analysis of Glioma Tissue Samples - Mayo Clinic

   The purpose of this study is to use stored glioma specimens stored by the Tissue Registry under the oversight of the Neuro-Oncology program. Participating Mayo ...

6. A Study of Shared Decision Making in Barrett’s Esophagus with Low Grade Dysplasia - Mayo Clinic

   To evaluate the impact of the developed decision aid (BE Choice) on patient-centered outcomes, assessments will be made of patient knowledge, decision conflict, ...

7. A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma

   A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma.

8. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study of Oral LGH447 in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   The primary purpose of this dose escalation study is to estimate the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE) of LGH447 as a ...

10. PK and Safety of Paclitaxel Injection Concentrate for Nano-dispersion Alone and in Carboplatin Combination - Mayo Clinic

    This is a phase I study of PICN alone and in combination with carboplatin and consisting of 2 sequential parts. Part A will characterize the pharmacokinetic ...